European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 
03 Sep 2006

Echocardiographic measurements in heart failure Symposium 

Gomez Zamorano 

Gomez Zamorano
Session number: 158000
Session title: Echocardiographic measurements in Heart Failure
Authors: Zamorano Gomez, J.L. Madrid, Spain
Heart failure is an increasing problem in cardiology. The different diagnostic and prognostic information provided by echocardiography in such patients was discussed during this session.

Dr G W A De Keulaner from Antwerp, Belgium, showed data regarding the limitations of using ejection fraction (EF) as a cornerstone of classifying patients with heart failure. From the pathophysiological point of view the importance of EF has been over emphasised. Just differentiating heart failure patients into two groups (more and less than 50% EF) is not enough to provide diagnostic and prognostic information. Modern technology, such as Strain DTI should be used. EF alone is too insensitive for both systolic and diastolic dysfunction.

Following this lecture Dr A G Fraser of Cardiff, Wales, discussed the reasons why indices of radial function are misleading. The anatomical characteristics and transmural changes during contraction or differences in longitudinal and radial function of the left ventricle, are different aspects that should be considered when assessing left ventricular function.

Dr F Pinto from Lisbon, Portugal, also showed some potential limitations of echocardiography in assessing LV mass and volumes. He highlighted the importance of quantifying in an accurate way, left ventricular mass and volumes. Such measurements have important prognostic information and could be used to monitor therapeutic aspects.

In order to avoid technical limitations and those derived from geometrical assumptions, new technologies, such as 3D echocardiography, have been developed. Dr Pinto showed some interesting data about how 3D echocardiography provides data, similar to those obtained with MRI, in the assessment of left ventricular volumes.

Conclusion The session ended with the presentation of Dr J E Sanderson of Stoke-on-Trent, England making some remarks on what should be measured in systolic and diastolic failure.

Starting with the key message that measuring volumes is more important than measuring EF, Dr Sanderson highlighted again the pathophysiological aspects of heart failure (remodelling) that should be monitored during the examination of heart failure patients.


The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.


 
Highlight On